(E)-1-(2,5-dimethoxyphenyl)-3-[2-[2-(dimethylamino)ethoxy]phenyl]prop-2-en-1-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(2,5-dimethoxyphenyl)-3-[2-[2-(dimethylamino)ethoxy]phenyl]prop-2-en-1-one
• 化学式: C₂₁H₂₅NO₄
• 分子量: 355.4
• InChiKey: NTYFWLDWZWFCJL-PKNBQFBNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  26
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  48
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Aminoalkoxy-functional chalcones
  申请人：Nielsen Feldbaek Simon

  公开号：US20050227990A1

  公开（公告）日：2005-10-13

  The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.

  本发明提供了新型的烷氧基氨基查尔酮衍生物及其类似物。本发明还揭示了将该化合物或包含它们的组合物用作药物活性剂，特别是用于对抗细菌和寄生虫感染。本发明还涉及一种检测抑制作用的方法，例如对细菌、寄生虫、真菌和蠕虫的抑制作用。本发明的查尔酮带有氨基取代基，并展示出增强的生物效应和改善的代谢和物理化学性质，使得该化合物可用作药物物质，特别是作为抗寄生虫、细菌静止和杀菌剂。
• AMINOALKOXY-FUNCTIONAL CHALCONES
  申请人：Lica Pharmaceuticals A/S

  公开号：EP1515940A2

  公开（公告）日：2005-03-23
• US7423181B2
  申请人：——

  公开号：US7423181B2

  公开（公告）日：2008-09-09
• [EN] AMINOALKOXY-FUNCTIONAL CHALCONES<br/>[FR] CHALCONES A FONCTION AMINOALKOXY
  申请人：LICA PHARMACEUTICALS AS

  公开号：WO2003097574A2

  公开（公告）日：2003-11-27

  The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is also disclosed. The invention further relates to a method for detecting inhibitory effects against e.g., bacteria, parasites, fungi, and helminths. The chalcones of the invention carry amino substituents and exhibit enhanced biological effects combined with improved metabolic and physicochemical properties, making the compounds useful as drug substances, in particular as antiparasitic, bacteriostatic, and bacteriocidal agents.